From a clinical perspective, unexplained loss of glycemic control or weight loss plateau after previously good response may suggest medication issues, though this requires careful differential diagnosis
Patients inflammatory markers improve
By meta-analysis of the individual cardiovascular endpoints, significant improvements were established for all of the following: myocardial infarction, stroke, cardiovascular mortality, all-cause mortality and hospitalisation for heart failure
When our bodies fat cells grow larger as we gain weight, it causes excess production of NNMT (Nicotinamide N-methyltransferase), a cytosolic enzyme that works to slow down fat cell metabolism
Unlike a single-purpose medication, it seems to reinforce the bodys innate repair machinery